MHRA: policy for handling corporate conflicts of interest
Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.
Documents
Details
This policy outlines the approach to handling potential corporate conflicts of interest (COI) between different parts of the Medicines and Healthcare products Regulatory Agency (MHRA), It sits alongside MHRA staff COI policy. We also publish our annual conflict of interest compliance reports here.
A corporate conflict of interest may arise where one part of the MHRA undertakes work that may require oversight or review by another part of MHRA now or in the future. The risk of an actual COI, or the perception of one, can arise where the MHRA is in a position where its decisions might be – or be seen to be – influenced by its other interests.